FDA Inspection 875272 — Angelini Pharma, Inc.

Angelini Pharma, Inc. — FEI 3001239013

The FDA completed an inspection of Angelini Pharma, Inc. on April 22, 2014 in Atlanta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 22, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Compliance: Devices
Location
Atlanta, GA (United States)

Citations

IDCFRDescription
340921 CFR 820.200(d)Service reports